Nonsteroidal anti-inflammatory drugs renal failure

In studies lasting 6 to 12 weeks, topical diclofenac and topical ketoprofen were significantly more effective than carrier for reducing pain; about 60% of participants had much reduced pain. With topical diclofenac, the NNT for clinical success in six trials (2343 participants) was (95% confidence interval ( CI ) to 16) (moderate quality evidence). With topical ketoprofen, the NNT for clinical success in four trials (2573 participants) was ( to ) (moderate quality evidence). There was too little information for analysis of other individual topical NSAIDs compared with carrier. Few trials compared a topical NSAID to an oral NSAID , but overall they showed similar efficacy (low quality evidence). These efficacy results were almost completely derived from people with knee osteoarthritis.

Nonsteroidal anti-inflammatory drugs renal failure

nonsteroidal anti-inflammatory drugs renal failure

Media:

nonsteroidal anti-inflammatory drugs renal failurenonsteroidal anti-inflammatory drugs renal failurenonsteroidal anti-inflammatory drugs renal failurenonsteroidal anti-inflammatory drugs renal failurenonsteroidal anti-inflammatory drugs renal failure